FAM99B and hepatocellular carcinoma: FAM99B inhibits rRNA processing and RPS29/RPL38 transcription via DDX21, leading to reduced ribosome biogenesis and decreased protein synthesis, resulting in inhibition of the proliferation and metastasis of HCC cells in vivo and in vitro.